Corbevax

Vaxxed to the max: A look at India's COVID vaccination drive that is set to overtake US, Europe and Canada combined

As per official data, a total of 1,96,24,21,213 doses have been administered so far across the country, which is set to cross the combined doses of the United States, Europe and Canada

DCGI approves Corbevax as first heterologous COVID-19 booster shot for adults

Biological E's clinical trial data showed that the Corbevax booster dose provided significant enhancement in immune response and the excellent safety profile required for an effective booster, said a statement issued by the company

COVID-19: Over 3 crore children between 12-14 years administered first vaccine dose

The vaccination for children between the 12-14 age group started on 16 March with Biological E's intramuscular vaccine Corbevax, which is administered to the beneficiaries in an interval of 28 days

Corbevax, Biological E's COVID-19 vaccine, gets DCGI's emergency use authorisation for children aged 5-12

The DCGI has also given restricted emergency use authorisation to Covaxin, manufactured by Hyderabad based pharmaceutical company - Bharat Biotech, for children between 6 and 12 years

India to begin vaccination drive for kids aged 5-12; Here’s all you need to know

Currently, India is administering two vaccines to children in the country

DCGI expert panel holds meet on recommendations to use Corbevax, Covaxin vaccines for 5-12 age group

India is currently administering two COVID-19 vaccines for children above 12

Vaxxed to the max: Two years on, India starts COVID-19 vaccination for 12-14 age group

The country's battle against the coronavirus pandemic began a new phase on Wednesday as children aged 12 to 14 years began to get their vaccine against the virus. Beneficiaries in this phase will receive Biological E's Corbevax vaccine

India starts vaccinating children in 12-14 age group with Corbevax: All you need to know about this 'game-changer' vaccine

Developed by the Hyderabad-based Biological E Ltd in India, this two-dose vaccine shows a 90 per cent effectiveness against the original Wuhan strain and more than 80 per cent against the Delta variant

India begins COVID-19 vaccine for kids aged 12-14 years, booster for all above 60 from today; All you need to know

The Centre has released guidelines for COVID-19 vaccination of children between 12-14 years. Two doses of Biological E's intramuscular vaccine Corbevax would be administered at an interval of 28 days

Centre releases guidelines for COVID-19 vaccination for kids between 12 to 14 years; Corbevax vaccine to be used

Two doses of Biological E's intramuscular vaccine Corbevax would be administered to the beneficiaries in the 12-14 years age group at an interval of 28 days, the guidelines said.